High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-β1 of human peritoneal mesothelial cells: Effect of cytokine costimulation

Peritoneal Dialysis International

Volumn 19, Issue 3, 1999, Pages 221-230

  Kang, Duk Hee ^a   Hong, Young Sook ^b   Lim, Hyun Joung ^b   Choi, Jin Hee ^b   Han, Dae Suk ^b   Yoon, Kyun Ll ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Cytokines; Mesothelial cells; Peritoneal fibrosis; TGF 1

Indexed keywords

CYTOKINE; GLUCOSE; INTERLEUKIN 1BETA; MANNITOL; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DIALYSATE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MESOTHELIUM CELL; MESSENGER RNA SYNTHESIS; NORTHERN BLOTTING; PERITONEUM CELL; PERITONITIS; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS;

EID: 0033385740     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089901900307     Document Type: Article

References (40)

1. Dobbie JW. New concepts in molecular biology and ultrastructural pathology of peritoneum: their significance for peritoneal dialysis. Am J Kidney Dis 1990; 15:97-100.
2. Hjelle JT, Miller-Hjelle MA, Dobbie JW. The biology of the mesothelium during peritoneal dialysis. Perit Dial Int 1995; 15(7)(Suppl):S13-23.
3. Brulez HFH, Verbrugh HA. First-line defense mechanisms in the peritoneal cavity during peritoneal dialysis. Perit Dial Int 1995; 15(7) (Suppl):S24-34.
4. van Bronswijk H, Verbrugh HA, Bos HJ, Heezius ECJM, Oe PL, van der Meulen J, et al. Cytotoxic effects of commercial CAPD fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit Dial Int 1989; 9:197-202.
5. Topley N, Mackenzie R, Petersen MM, Beavis MJ, Williams D, Thomas N, et al. In vitro testing of a potentially biocompatible CAPD fluid. Nephrol Dial Transplant 1991; 6:574-81.
6. Gotloib L, Wajsbrot V, Shostak A, Kushnier R. Morphology of the peritoneum: effect of peritoneal dialysis. Perit Dial Int 1995; 15(7) (Suppl):S9-12.
7. Slater ND, Cope GH, Raftery AT. Mesothelial hyperplasia in response to peritoneal dialysis fluid: a morphometric study in the rat. Nephron 1991; 58:466-71.
8. Dobbie JW. Pathogenesis of peritoneal fibrosing syndrome (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12:14-27.
9. Nolph KD. Clinical results with peritoneal dialysis. Registry experiences. In: Twardowski ZJ, Nolph KD, Khanna R, Stein JH, eds. Peritoneal dialysis. Contemporary issues in nephrology. New York: Churchill Livingston, 1991:127-44.
10. Finkelstein SM, Sorkin M, Cramton CW, Nolph KD. Initiatives in peritoneal dialysis: where do we go from here? Perit Dial Int 1991; 11:274-8.
11. Massagué J. The transforming growth factor-β family. Annu Rev Cell Biol 1990; 6:597-642.
12. Ziyadeh FN, Sharma K, Ericksen M, Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 1994; 93:536-42.
13. Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN. Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule. Kidney Int 1992; 41:107-14.
14. 1 expression in peritoneal mesothelial cell. In: Khanna R, ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1995; 11:7-10.
15. Kumano K, Schiller-Moran B, Hjelle JT, Moran JE. Effects of high glucose levels on cell proliferation and TGF-β expression in cultured rat mesothelial cell (Abstract). J Am Soc Nephrol 1993; 4:410.
16. Zemel D, Koomen GCM, Hart AAM, Ten Berge IJM, Struijk DG, Krediet RT. Relationship of TNF-α, interleukin-6 and prostaglandins to peritoneal permeability for macromolecules during longitudinal followup of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 1993; 122:686-96.
17. Brauner A, Hylander B, Wretlind B. Tumor necrosis factor-α, interleukin-1β, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 27:402-8.
18. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37:1563-70.
19. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenolchloroform extraction. Anal Biochem 1987; 162:156-9.
20. Maniatis T, Fritsch EF, Sambrook J, eds. Molecular cloning. A laboratory manual. New York: Cold Spring Har-bor Laboratory Press, 1989.
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
22. Gotloib L, Wajsbrot V, Shostak A, Kushnier R. Experimental approach to peritoneal morphology. Perit Dial Int 1994; 14(Suppl 3):S6-11.
23. Dobbie JW, Anderson JD, Hind C. Long-term effects of peritoneal dialysis on peritoneal morphology. Perit Dial Int 1993; 13(Suppl 2):S23-6.
24. Dobbie JW. Durability of the peritoneal membrane. Perit Dial Int 1995; 15(7) (Suppl):S87-92.
25. Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest 1992; 90:1-7.
26. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, et al. Natural inhibitor of transforming growth factor-ß protects against scarring in experimental kidney disease. Nature 1992; 360:361-4.
27. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, et al. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987; 84:6020-4.
28. Roberts AB, McCune BK, Sporn MB. TGF-β: regulation of extracellular matrix. Kidney Int 1992; 41:557-9.
29. Ignotz RA, Massagué J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261:4337-45.
30. Kang DH, Yoon KI. Impacts of the composition of peritoneal dialysate on the proliferation and the viability of cultured human peritoneal mesothelial cell (Abstract). Perit Dial Int 1998; 18(Suppl 2):S69.
31. Roberts AB, Kim SJ, Noma T. Multiple forms of TGF-β: distinct promoters and differential expression. In: Sporn MB, Roberts AB, eds. Clinical applications of TGF-β. Ciba Foundation Symposium. Chichester, UK: Wiley, 1991:7-28.
32. Kreisberg JI, Radnik RA, Ayo SH, Garoni J, Saikumar P. High glucose elevated c-fos and c-jun transcripts and proteins in mesangial cell culture. Kidney Int 1994; 46:105-12.
33. Gharary A, Shen Q, Shen YJ, Scott PH, Tredget EE. Induction of transforming growth factor beta 1 by insulin-like growth factor-1 in dermal fibroblast. J Cell Physiol 1998; 174:301-9.
34. Flanders KC, Holder MG, Winokur TS. Autoinduction of mRNA and protein expression for transforming growth factor-betas in cultured cardiac cells. J Mol Cell Cardial 1995; 27:805-12.
35. Lin CY, Chen WP, Fu LW, Yang LY, Huang TP. Persistent transforming growth factor P1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence. In: Khanna R, ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1997; 13:64-71.
36. Offner FA, Feichtinger H, Stadlmann S, Obrist P, Marth C, Klinger P, et al. Transforming growth factor-β synthesis by human peritoneal mesothelial cells. Am J Pathol 1996; 148:1679-88.
37. Topley N, Jörres A, Luttmann W, Petersen MM, Lang MJ, Thierauch KH, et al. Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1β and TNFα. Kidney Int 1993; 43:226-33.
38. Yung S, Coles GA, Davies M. IL-1β, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD. Kidney Int 1996; 50:1337-43.
39. Witowski J, Jörres A, Coles GA, Williams JD, Topley N. Superinduction of IL-6 synthesis in human peritoneal mesothelial cells is related to the induction and stabilization of IL-6 mRNA. Kidney Int 1996; 50:1212-23.
40. Phillips AO, Steadman R, Topley N, Williams JD. Elevated D-glucose concentrations modulate TGF-β synthesis by human cultured renal proximal tubular cells. The permissive role of platelet-derived growth factor. Am J Pathol 1995; 147:362-74.